Literature DB >> 17030780

ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease.

M He1, T Ohrui, M Maruyama, N Tomita, K Nakayama, M Higuchi, K Furukawa, H Arai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17030780     DOI： 10.1212/01.wnl.0000238102.04582.ec

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  12 in total

1.  Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

Authors:  Linda Ferrington; Laura E Palmer; Seth Love; Karen J Horsburgh; Paul At Kelly; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2012-04-12       Impact factor: 4.060

2.  Moringa oleifera supplemented diet modulates nootropic-related biomolecules in the brain of STZ-induced diabetic rats treated with acarbose.

Authors:  Ganiyu Oboh; Sunday I Oyeleye; Omoyemi A Akintemi; Tosin A Olasehinde
Journal:  Metab Brain Dis       Date:  2018-02-12       Impact factor: 3.584

3.  Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.

Authors:  Vincenzo Solfrizzi; Emanuele Scafato; Vincenza Frisardi; Davide Seripa; Giancarlo Logroscino; Patrick G Kehoe; Bruno P Imbimbo; Marzia Baldereschi; Gaetano Crepaldi; Antonio Di Carlo; Lucia Galluzzo; Claudia Gandin; Domenico Inzitari; Stefania Maggi; Alberto Pilotto; Francesco Panza
Journal:  Age (Dordr)       Date:  2011-12-28

4.  ACE variants and association with brain Aβ levels in Alzheimer's disease.

Authors:  J Scott Miners; Zoë van Helmond; Merryn Raiker; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2010-10-15       Impact factor: 4.060

5.  Angiotensin-converting enzyme gene insertion-deletion polymorphism is a risk marker for Alzheimer's disease in a Chinese population: a meta-analysis of case-control studies.

Authors:  Ye Yuan; Jin-hua Piao; Ke Ma; Na Lu
Journal:  J Neural Transm (Vienna)       Date:  2015-01-18       Impact factor: 3.575

6.  Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

Authors:  Scott Miners; Emma Ashby; Shabnam Baig; Rachel Harrison; Hannah Tayler; Elizabeth Speedy; Jonathan A Prince; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2009-01-18       Impact factor: 4.060

7.  Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients.

Authors:  Pradeep K Singh; Zu-Lin Chen; Dhiman Ghosh; Sidney Strickland; Erin H Norris
Journal:  Neurobiol Dis       Date:  2020-03-12       Impact factor: 5.996

8.  Effects of age, genes, and pulse pressure on executive functions in healthy adults.

Authors:  Naftali Raz; Cheryl L Dahle; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neurobiol Aging       Date:  2009-06-25       Impact factor: 4.673

9.  Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.

Authors:  John S K Kauwe; Matthew H Bailey; Perry G Ridge; Rachel Perry; Mark E Wadsworth; Kaitlyn L Hoyt; Lyndsay A Staley; Celeste M Karch; Oscar Harari; Carlos Cruchaga; Benjamin J Ainscough; Kelly Bales; Eve H Pickering; Sarah Bertelsen; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  PLoS Genet       Date:  2014-10-23       Impact factor: 5.917

10.  Chronic inhibition of central Angiotensin-converting enzyme ameliorates colchicine-induced memory impairment in mice.

Authors:  Himani Awasthi; Deep Kaushal; Hefazat Husain Siddiqui
Journal:  Sci Pharm       Date:  2012-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.